期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 171 ()
Lung cancer organoids (LCOs) have sprung up in more and more researching fields, because of their ability to recapitulate the three-dimensional struct......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 173 ()
To summarize randomized controlled trials (RCTs) evidence for the effectiveness of available treatment strategies for elderly patients with glioblasto......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 170 ()
To date, there is no approved biomarker for predicting pathological response in neoadjuvant programmed cell death (ligand) 1 (PD-(L)1) blockades treat......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 172 ()
Based on clinical trials demonstrating favorable short-term efficacy and tolerable toxicity, several tyrosine kinase inhibitors have been approved for......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 179 ()
The transcription factors (TFs) of the HOX family play significant roles during early embryonic development and cellular processes. They also play a k......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 176 ()
Prostate cancer (PCa) is a highly prevalent disease that affects men's health worldwide and is the second most common malignancy in males. Ferroptosis......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 179 ()
Circulating tumor DNA (ctDNA) in the bloodstream can be used to reliably identify a minimal residual disease (MRD). ctDNA-MRD has demonstrated clinica......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()
As a potential biomarker to predict the response to immunotherapy, tumor mutation burden (TMB) which can be estimated by the cancer gene panel (CGP) h......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 171 ()
For advanced cancers of the digestive system, personalized, precise treatment can be life saving. With the development of next-generation sequencing t......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 177 ()
Background: A growing number of regimens have been approved as first-line treatments for patients with advanced epidermal growth factor receptor (EGFR......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 179 ()
Allogeneic anti-CD19 chimeric antigen receptor (CAR) T-cell therapy has the potential for extensive clinical applications. This study aimed to evaluat......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 177 ()
This study was undertaken to evaluate the prognostic significance of circulating tumour DNA (ctDNA) detection at different time periods in resectable ......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 175 ()
Autophagy is a highly conserved metabolic process with a cytoprotective function. Autophagy is involved in cancer, infection, immunity, and inflammati......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()
Lung cancer has attracted much attention because of its high morbidity and mortality worldwide. The advent of immunotherapy approaches, especially the......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 179 ()
Understanding the burden of mesothelioma with the contribution of occupational asbestos exposure globally provides essential foundations for cancer co......
